In studies in mice, Johns Hopkins Medicine researchers say they have identified a chemical compound that stops the final events in the pathway linked to the death of brain cells in Parkinson’s disease. Results of the experiments, they say, could advance the development of a drug that can safely short-circuit the same pathway in people, and prevent the damaging effects characteristic of Parkinson’s, stroke and other neurodegenerative disorders.
Chemical inhibitor blocks final path to cell death in mice with Parkinson’s symptoms
In studies in mice, Johns Hopkins Medicine researchers say they have identified a chemical compound that stops the final events in the pathway linked to the death of brain cells in Parkinson's disease. Results of the experiments, they say, could advance the development of a drug that can safely short-circuit the same pathway in people, and prevent the damaging effects characteristic of Parkinson's, stroke and other neurodegenerative disorders.